Displaying all 5 publications

Abstract:
Sort:
  1. Abdullah B, Subramaniam R, Omar S, Wragg P, Ramli N, Wui A, et al.
    Biomed Imaging Interv J, 2010 Apr-Jun;6(2):e15.
    PMID: 21611036 MyJurnal DOI: 10.2349/biij.6.2.e15
    Magnetic Resonance-guided focused Ultrasound Surgery (MRgFUS) is gaining popularity as an alternative to medical and surgical interventions in the management of symptomatic uterine fibroids. Studies have shown that it is an effective non-invasive treatment with minimal associated risks as compared to myomectomy and hysterectomy. MRgFUS can be offered to a majority of patients suffering from symptomatic uterine fibroids. It has been suggested that the use of broader inclusion criteria as well as the mitigation techniques makes it possible to offer MRgFUS to a much larger subset of patients than previously believed. This paper will describe how MRgFUS treatment for uterine fibroids is performed at the University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Matched MeSH terms: Uterine Myomectomy
  2. Nor Amirawati, A., Anizah, A., Shafiee, M,N.
    MyJurnal
    Myomectomy is rarely performed in pregnancy due to risk of miscarriage or pregnancy loss, bleeding and possible
    hysterectomy. Myomectomy is mainly reserved for unavoidable indications such as rapidly growing fibroid or severe
    pain with possiblity of red degeneration for which medical treatment failed. However, good outcome had been
    reported in selective second trimester myomectomies.
    Matched MeSH terms: Uterine Myomectomy
  3. Ahmad MF, Sheng KL, Kathirgamanathan S, Kannaiah K
    Minerva Ginecol, 2018 10;70(5):644-645.
    PMID: 29464941 DOI: 10.23736/S0026-4784.18.04183-7
    Matched MeSH terms: Uterine Myomectomy/methods*
  4. Tan YL, Lo TS, Khanuengkitkong S, Dass AK
    Taiwan J Obstet Gynecol, 2013 Sep;52(3):435-6.
    PMID: 24075389 DOI: 10.1016/j.tjog.2013.01.027
    Matched MeSH terms: Uterine Myomectomy/adverse effects*
  5. Seong Tan PC, Nik Mohamad NA, Gan SH
    Pain Manag Nurs, 2013 Jun;14(2):102-9.
    PMID: 23688364 DOI: 10.1016/j.pmn.2010.12.004
    The association between pain intensity and its control by intravenous patient-controlled analgesia (IV-PCA) with fentanyl after a laparotomy for cystectomy/salphingoophorectomy, myomectomy, or hysterectomy was investigated. IV fentanyl infusion was administered to patients (n = 94) at 3 μg/kg/h to provide intraoperative analgesia after induction of general anesthesia. Postoperative fentanyl requirements were quantified via IV-PCA, and the amounts of rescue fentanyl required both during and after surgery were recorded. Mean values for PCA use as well as the visual analog scores (VAS) for pain were documented for up to 24 hours. The association between postoperative fentanyl requirements and VAS were then analyzed by using Mann-Whitney or Kruskal-Wallis tests. Patients with lower midline incisions had greater degrees of pain (p < .05) during the first 16 hours after surgery but did not consume more fentanyl compared with patients with Pfannenstiel incisions. Subjects who underwent operations lasting >4 hours required more rescue fentanyl during surgery (p < .05). However, this group consumed less fentanyl during the first 4 hours after surgery (p < .05). The demand at the fourth 4-hour period was lower among subjects undergoing myomectomy compared with cystectomy/salphingoophorectomy or hysterectomy (p = .045). Only a poor correlation was observed between pain intensity and analgesic usage. Postoperative pain intensity is influenced by the type of surgical incision but not the type of gynecologic surgery nor the duration of surgery. The relationship between subjective pain ratings with analgesic consumption is weak. Prolonged intraoperative administration of continuous IV fentanyl infusion may reduce fentanyl requirements in the immediate postoperative period.
    Matched MeSH terms: Uterine Myomectomy/adverse effects
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links